Clinical trial
Determination of the Role of Microarray for Prognosis and Prediction to…
NCT00220077 · Royal Marsden NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00220077 |
|---|---|
| Title | Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer |
| Official title | Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Oesophageal Cancer |
| Intervention type | Procedure |
| Interventions | Endoscopy |
| Enrollment | 400 |
| Start date | Jun 1, 2002 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 25, 2015 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: